News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sagent Pharmaceuticals, Inc. Announces the Launch of Ondansetron Injection, USP


9/10/2012 9:07:08 AM

SCHAUMBURG, Ill., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Ondansetron Injection, USP, an antiemetic, in two latex-free vial presentations. According to IMS, for the 12 months ending June 2012, the US market for Ondansetron Injection, USP approximated $49 million. As with all products in Sagent's portfolio, Ondansetron features the company's PreventIV MeasuresSM packaging and labeling, designed to help reduce medication errors.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES